Kent Holtorf, MD - Thyroid Disorders (2016 Conference) (LDN, low dose naltrexone)


Kent Holtorf, MD - Thyroid Disorders (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Holtorf's Thyroid Presentation

Hashimoto’s is generally described as TH1 dominant and Graves’ as TH2 with significant individual variation. It can be either TH1 or TH2 dominant and Low dose naltrexone (LDN) can potentially be useful for both. 

Dr Holtorf explains the required steps for cellular thyroid activity. He explains how it is diagnosed and why the TSH test is so unreliable. He then presents slides that explain the following:

Accuracy of TSH in Fibromyalgia, Accuracy of TSH in Chronic Fatigue, Accuracy of TSH with PMS, Accuracy of TSH with Obesity, Thyroid Levels with Insulin Resistance and Diabetes, Thyroid and Leptin, Thyroid Hormone Transport, Reverse T3 (blocks cellular uptake of T4 and T3), Thyroid Resistance, Almost all CFS/FM are low thyroid, Diagnosis Sex Hormone-binding Globulin (SHBG).

Dr Holtorf concludes with “Low Dose Naltrexone (LDN) can be effective for autoimmune Thyroiditis.  LDN can potentially improve tissue thyroid levels in conditions associated with immune dysfunction and inflammation by improving thyroid resistance (due to reduced T4 to T3 conversion, impaired thyroid transport and leptin resistance)”. 

For more presentations regarding the use of LDN in many conditions please visit